Taking statins after being diagnosed with aggressive breast cancer raises the survival rate by 58 per cent, a study has found.

Researchers have found a 'significant association' between taking the common cholesterol-lowering drugs and survival rates of triple-negative breast cancer (TNBC).

TNBC makes up 10 to 20 per cent of breast cancer diagnoses, with about 8,000 patients found to have it in the UK each year. .

Researchers have found a 'significant association' between taking the common cholesterol-lowering drugs and survival rates of triple-negative breast cancer (TNBC).

Lead author Dr Kevin Nead said: 'There is already a body of literature on statins and breast cancer and the results have been inconsistent

TNBC makes up 10 to 20 per cent of breast cancer diagnoses, with about 8,000 patients found to have it in the UK each year